Ocumension Therapeutics (HKG:1477)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.06
-0.09 (-1.75%)
Jul 31, 2026, 4:08 PM HKT

Ocumension Therapeutics Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-158.82-268.27-379.79-402.64-259.99
Depreciation & Amortization
141.5585.6757.5440.4613.9
Other Amortization
2.182.95---
Asset Writedown & Restructuring Costs
---3.183.18-
Loss (Gain) From Sale of Investments
-3.27-0.29-1.16-1.25-125.78
Loss (Gain) on Equity Investments
----13.33
Stock-Based Compensation
68.9484.63139.73218.79188.12
Provision & Write-off of Bad Debts
0.650.650.350.68-
Other Operating Activities
-2.08-22.34-24.57-479.07
Change in Accounts Receivable
-179.39-38.93-7.65-33.28-31.15
Change in Inventory
-18.4-13.05-13-19.11-1.97
Change in Accounts Payable
44.32-11.3449.5734.42-2.39
Change in Unearned Revenue
-0.981.5-30.09-
Change in Other Net Operating Assets
--4.25-25-
Operating Cash Flow
-105.29-178.83-177.93-200.66-196.85
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-28.88-47.1-80.91-115.81-195.37
Sale (Purchase) of Intangibles
-224.48-183.05-280.96-194.19-469.44
Investment in Securities
-114.46470.4653.22522.86-697.79
Other Investing Activities
6.3735.648.8616.2917.31
Investing Cash Flow
-361.46275.91-259.78229.15-1,345

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
158.0646.55120--
Long-Term Debt Repaid
-26.23-163.5-14.25-9.15-3.82
Total Debt Repaid
-26.23-163.5-14.25-9.15-3.82
Net Debt Issued (Repaid)
131.83-116.95105.75-9.15-3.82
Issuance of Common Stock
4.960.985.612.72684.73
Repurchase of Common Stock
-16.39-95.57-1.46-11-1.39
Other Financing Activities
-2.36-2.25-1.22-1.79-10.68
Financing Cash Flow
118.04-213.79108.66-9.22668.85

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-3.033.071.8425.56-35.81
Net Cash Flow
-351.74-113.63-327.2144.83-909.1

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-134.17-225.92-258.84-316.47-392.22
Free Cash Flow Growth
-----
Free Cash Flow Margin
-16.68%-54.14%-105.06%-199.09%-698.57%
Free Cash Flow Per Share
-0.17-0.33-0.40-0.50-0.65
Levered Free Cash Flow
-433.07-344.38-480.3-404.46-580.44
Unlevered Free Cash Flow
-431.54-343.03-479.47-403.33-580.09

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
2.362.251.221.790.57
Cash Income Tax Paid
1.360.32-0.030.41-
Change in Working Capital
-154.45-61.8233.15-12.88-35.5